NASDAQ:KTTA
Pasithea Therapeutics Corp.
- Stock
Last Close
4.56
26/07 20:00
Market Cap
5.45M
Beta: -
Volume Today
2.75K
Avg: 58.36K
PE Ratio
−0.56
PFCF: −0.43
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -549.61K - | -727.95K 32.45% | -1.53M 109.64% | 630.12K 141.29% | -1.57M 349.83% | -2.66M 68.87% | -4.59M 72.52% | -5.12M 11.59% | -3.27M 36.19% | -3.60M 10.17% | -3.61M 0.40% | -5.03M 39.27% | -3.86M 23.26% | |
depreciation and amortization | 1.38K - | 5.01K 263.60% | 10.79K 115.14% | 16.67K 54.54% | -97 100.58% | 161.72K 166,821.65% | 162.26K 0.33% | 162.26K 0.00% | 162.22K 0.02% | 162.26K 0.02% | ||||
deferred income tax | -2.59M - | -578.16K - | 538.14K 193.08% | |||||||||||
stock based compensation | 15K - | 156.59K 943.90% | 135.63K 13.38% | 559.33K 312.39% | -298.31K 153.33% | 156.17K 152.35% | 177.02K 13.35% | 218.63K 23.51% | 126.67K 42.06% | 346.48M - | ||||
change in working capital | 167.76K - | 211.70K 26.19% | -354.73K 267.56% | 86.49K 124.38% | -308.58K 456.77% | 132.95K 143.08% | -988.51K 843.52% | 1.03M 203.76% | -323.04K 131.49% | 315.04K 197.52% | 129.85K 58.78% | 1.45M 1,018.46% | -942.26K 164.88% | |
accounts receivables | ||||||||||||||
inventory | ||||||||||||||
accounts payables | 440.68K - | -13.60K 103.09% | 831.64M - | -33.85M 104.07% | -118.37M - | |||||||||
other working capital | -354.18K - | -294.99K 16.71% | -988.51K - | -830.61M 83,926.73% | 33.85M 104.08% | 315.04K 99.07% | 129.85K 58.78% | 1.45M 1,018.46% | -942.26K 164.88% | |||||
other non cash items | 16.80K - | 1.32M 7,739.17% | -32.51K 102.47% | -785.30K 2,315.33% | -421.70K 46.30% | 617.56K 246.44% | -482.79K 178.18% | 47.83K 109.91% | 960 97.99% | 960 0% | 105.47K 10,886.67% | 644.28K 510.85% | ||
net cash provided by operating activities | -381.85K - | -499.44K 30.80% | -548.44K 9.81% | -1.74M 218.05% | -2.53M 44.90% | -2.38M 5.95% | -5.24M 120.39% | -4.42M 15.65% | -3.20M 27.53% | -3.48M 8.65% | -2.65M 23.70% | -3.31M 24.73% | -4.32M 30.50% | |
investments in property plant and equipment | -12.93K - | -113.87K 780.44% | -38.31K 66.36% | -197.45K 415.39% | -1.79M 806.06% | -53.89K 96.99% | -3.11K 94.23% | 22.66K 829.05% | 36 99.84% | |||||
acquisitions net | -32.98K - | 32.98K 200% | 27.50K - | 27.50K 0% | 54.50K 98.18% | |||||||||
purchases of investments | ||||||||||||||
sales maturities of investments | ||||||||||||||
other investing activites | 77.06K - | 319.62K - | ||||||||||||
net cash used for investing activites | -8.57K - | -12.93K 50.91% | -113.87K 780.44% | 38.75K 134.03% | -230.43K 694.66% | -1.76M 662.06% | -53.89K 96.93% | 344.01K 738.38% | 50.16K 85.42% | 54.54K 8.73% | ||||
debt repayment | -128.25K - | -130.77K 1.96% | -133.34K 1.96% | |||||||||||
common stock issued | 1.21M - | 21.86M - | 27.17M 24.26% | |||||||||||
common stock repurchased | -3.73M - | |||||||||||||
dividends paid | ||||||||||||||
other financing activites | -1.31M - | 7M 635.41% | -3.21M - | 392.35K 112.24% | -594.38K - | |||||||||
net cash used provided by financing activities | 1.21M - | 20.55M - | 34.17M 66.22% | -1.03M - | -3.21M 212.22% | 264.10K 108.24% | -130.77K 149.51% | -4.45M 3,306.13% | ||||||
effect of forex changes on cash | -1.45K - | -6.80K 368.90% | -4.16K 38.89% | -42.85K 931.31% | -72.69K 69.64% | 129.60K 278.28% | -2.48K 101.92% | -317 87.23% | -4.26K 1,242.59% | |||||
net change in cash | 827.08K - | -501.75K 160.67% | 20.00M 4,085.32% | 32.40M 62.04% | -2.65M 108.16% | -2.38M 9.99% | -5.54M 132.74% | -9.25M 66.94% | -3.17M 65.69% | -3.27M 2.92% | -7.06M 116.23% | -3.25M 53.93% | -4.32M 32.83% | |
cash at beginning of period | 243.65K - | 1.07M 339.45% | 568.98K 46.86% | 20.57M 3,514.41% | 52.97M 157.55% | 50.32M 4.99% | 47.94M 4.73% | 42.40M 11.56% | 33.09M 21.96% | 29.91M 9.59% | 26.65M 10.92% | 19.58M 26.50% | 16.33M 16.61% | |
cash at end of period | 1.07M - | 568.98K 46.86% | 20.57M 3,514.41% | 52.97M 157.55% | 50.32M 4.99% | 47.94M 4.73% | 42.40M 11.56% | 33.15M 21.82% | 29.91M 9.75% | 26.65M 10.92% | 19.58M 26.50% | 16.33M 16.61% | 12.01M 26.46% | |
operating cash flow | -381.85K - | -499.44K 30.80% | -548.44K 9.81% | -1.74M 218.05% | -2.53M 44.90% | -2.38M 5.95% | -5.24M 120.39% | -4.42M 15.65% | -3.20M 27.53% | -3.48M 8.65% | -2.65M 23.70% | -3.31M 24.73% | -4.32M 30.50% | |
capital expenditure | -12.93K - | -113.87K 780.44% | -38.31K 66.36% | -197.45K 415.39% | -1.79M 806.06% | -53.89K 96.99% | -3.11K 94.23% | 22.66K 829.05% | 36 99.84% | |||||
free cash flow | -381.85K - | -499.44K 30.80% | -548.44K 9.81% | -1.76M 220.41% | -2.64M 50.31% | -2.42M 8.56% | -5.44M 125.07% | -6.21M 14.19% | -3.26M 47.55% | -3.48M 6.95% | -2.63M 24.42% | -3.31M 25.80% | -4.32M 30.50% |
All numbers in USD (except ratios and percentages)